LL
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release | Diabetes |  | 2024 | 360 | 3 | ||
| Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes | Biochimica et biophysica acta. G, General subjects | | 2023 | 89 | 0 | ||
| Circulating 1,5-anhydroglucitol as a biomarker of ß-cell mass independent of a diabetes phenotype in human subjects | Journal of clinical endocrinology & metabolism | | 2022 | 406 | 2 | ||
| In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way | Journal of Biological Chemistry |  | 2019 | 452 | 118 | ||
| Reply to Mishra: prohibitin heterodimers—a complex time dependence for carcinogenesis | Journal of Biological Chemistry | | 2019 | 308 | 88 | ||
| Metabolomics identifies a biomarker revealing in vivo loss of functional ß-cell mass before diabetes onset | Diabetes | | 2019 | 376 | 992 | ||
| Liver Glutamate Dehydrogenase Controls Whole-Body Energy Partitioning Through Amino Acid-Derived Gluconeogenesis and Ammonia Homeostasis | Diabetes | | 2018 | 410 | 599 | ||
| Mitochondrial function and morphology in prohibitin 2 deleted ß-cells and hepatocytes | | 2017 | 715 | 13 |
